In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transfer

2001 ◽  
Vol 18 (4) ◽  
pp. 491-506 ◽  
Author(s):  
S. Armeanu, I. Haessler, R. Saller,
Blood ◽  
1997 ◽  
Vol 90 (5) ◽  
pp. 1777-1786 ◽  
Author(s):  
Derek A. Persons ◽  
James A. Allay ◽  
Esther R. Allay ◽  
Richard J. Smeyne ◽  
Richard A. Ashmun ◽  
...  

Abstract We have investigated the utility of the green fluorescent protein (GFP) to serve as a marker to assess retroviral gene transfer into hematopoietic cells and as a tool to identify and enrich for cells expressing high levels of the vector-encoded transcript. GFP, by virtue of a naturally occurring chromophore encoded in its primary sequence, displays autonomous fluorescence, thus eliminating the need for antibody or cytochemical staining to detect its expression. A bicistronic murine stem cell virus (MSCV)-based retroviral vector was constructed containing the GFP cDNA and a mutant, human dihydrofolate reductase gene. High-titer, ecotropic retroviral producer cells free of replication competent virus were generated and used to transduce murine bone marrow cells by cocultivation. Within 24 hours after completion of the transduction procedure, a high proportion (40% to 70%) of the marrow cells were intensely fluorescent compared to mock-transduced cells or cells transduced with a control retrovirus. Erythroid and myeloid hematopoietic colonies derived from GFP-transduced marrow were easily scored for retroviral gene transfer by direct in situ fluorescence microscopy. Clonogenic progenitors expressing increased levels of antifolate drug resistance could be enriched from the GFP-transduced marrow population by fluorescence activated cell sorting of cells expressing high levels of GFP. In vivo, splenic hematopoietic colonies and peripheral blood cells from animals transplanted with GFP-transduced marrow displayed intense fluorescence. These results show that GFP is an excellent marker for scoring and tracking gene-modified hematopoietic cells and for allowing rapid selection and enrichment of transduced cells expressing high levels of the transgene.


1998 ◽  
Vol 94 (s38) ◽  
pp. 2P-2P
Author(s):  
SJ Forbes ◽  
M Themis ◽  
C Selden ◽  
HJF Hodgson

Gene Therapy ◽  
2007 ◽  
Vol 14 (21) ◽  
pp. 1537-1542 ◽  
Author(s):  
Y S Gong ◽  
K L Zhang ◽  
X G Jiang ◽  
Z W Wang ◽  
Z Q Sun ◽  
...  

1991 ◽  
Vol 2 (1) ◽  
pp. 27-32 ◽  
Author(s):  
Michael Kaleko ◽  
J. Victor Garcia ◽  
A. Dusty Miller

2010 ◽  
Vol 47 (7-8) ◽  
pp. 1619-1628 ◽  
Author(s):  
Sonja Kothlow ◽  
Katharina Schenk-Weibhauser ◽  
Michael J.H. Ratcliffe ◽  
Bernd Kaspers

1998 ◽  
Vol 4 (1) ◽  
pp. 78-88 ◽  
Author(s):  
Kouji Tada ◽  
Namita Roy Chowdhury ◽  
David Neufeld ◽  
Piter J. Bosma ◽  
Michele Heard ◽  
...  

1992 ◽  
Vol 90 (6) ◽  
pp. 2598-2607 ◽  
Author(s):  
J F Engelhardt ◽  
J R Yankaskas ◽  
J M Wilson

2012 ◽  
Vol 7 (6) ◽  
pp. 1167-1183 ◽  
Author(s):  
Alexander von Werder ◽  
Barbara Seidler ◽  
Roland M Schmid ◽  
Günter Schneider ◽  
Dieter Saur

Sign in / Sign up

Export Citation Format

Share Document